US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Virtual Genetics launches the next generations search engine - Sentensa

Sentensa is a new product that uses unique technology to search all kinds of text and databases. Sentensa is being launched as an Open Source product, which means that it is free and available for downloading via Internet. Sentensa’s dynamic, web-based technology is adapted for safe, multi-user application.Sentensa, has used 20 years experience in search technology to create the next generation search motor. Users have the ability to use totally new ways of searching amongst very large text databases. The name Sentensa was chosen in order to describe how that it takes into account search

Virtual Genetics signs license order with Celera Genomics

Virtual Genetics signs license order with Celera Genomics Virtual Genetics announced today that Celera Genomics has chosen to license Virtual Genetics bioinformatic text mining technology. The contract provides initially for the integration and customisation of Virtual Genetics' product Virtual Adapt to handle Celera's internal and external needs for literature searching and analysis. The order value is $400.000 including professional services and support. "Celera chose Virtual Adapt as both our internal and external literature mining platform because of the unique pattern matching

Change in management at Virtual Genetics

Change in management at Virtual Genetics Board member Johan Emilsson appointed as acting MD of bioinformatics company Virtual Genetics is strengthening its strategic positioning towards bioinformatics solutions whilst modifying its delivery model to the market. Johan Emilsson, with solid experience in profitable product-based consultancy, will head up the restructuring of the company, says Christer Sjölin, Chairman of the Board for Virtual Genetics. For further information: Bo Lindström, Investor Relations. Tel. 08 - 508 84 400/402 Nordiska Fondkommission AB publishes current buying and

Group press release of unaudited annual earnings figures for July-December 2000

Group press release of unaudited annual earnings figures for July-December 2000 Virtual Genetics Laboratory AB (VGL) has concluded its shortened financial year, July-December 2000. The company has continued its development and operations according to plan and has received its first commercial order from the drug industry. There has been further financing by means of two new share issues in collaboration with Nordiska Fondkommission AB. During the course of the financial year Virtual Genetics has focused on customer contacts, development work and continued recruitment. As the new financial

There are no items matching the current filter
There are no more items matching the current filter
Back to top